Mathematical model and tool to explore shorter multi-drug therapy options for active pulmonary tuberculosis
Fig 6
Reduced successful therapy outcome with variations of standard drug therapy.
Comparison of patient outcomes for treatment of the median outcome of TB infection, with standard drug therapy (2HREZ/4HR) vs. median outcome of therapy excluding isoniazid, 1200 mg rifampin and reduced treatment time. Based on simulation of 5000 patients.